A cost minimisation analysis of NOACs compared to warfarin to attain therapeutic anticoagulation amongst AF patients, pre- and post-cardioversion
dc.contributor.author | O'Shea, M. | |
dc.contributor.author | Murphy, Aileen | |
dc.contributor.author | Kirby, Ann | |
dc.contributor.author | Allen, G. | |
dc.contributor.author | O'Shea, S. | |
dc.contributor.author | Curtin, R. | |
dc.date.accessioned | 2018-02-09T12:16:20Z | |
dc.date.available | 2018-02-09T12:16:20Z | |
dc.date.issued | 2016-11 | |
dc.date.updated | 2018-01-26T12:39:13Z | |
dc.description.abstract | Atrial fibrillation can be managed with anticoagulation and restoration of normal sinus rhythm using direct current cardioversion (DCCV). To reduce the risk of thromboembolism anticoagulation pre-and-post DCCV is recommended. This study investigates the cost effectiveness of using NOACs compared to warfarin to attain therapeutic anticoagulation amongst AF patients pre-and-post DCCV. Propensity score matching revealed no statistically significant difference in outcomes from using NOACs and Warfarin. A cost minimisation study was performed; demonstrating a cost differential of €209 between those administered NOACs and warfarin pre and post DCCV. This study demonstrates how using NOACs compared to warfarin to attain therapeutic anticoagulation amongst AF patients preand-post DCCV is cost effective. | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | O'Shea, M., Murphy, A., Kirby, A., Allen, G., O'Shea, S. and Curtin, R. (2016) 'A cost minimisation analysis of NOACs compared to warfarin to attain therapeutic anticoagulation amongst AF patients, pre- and post-cardioversion', Irish Medical Journal, 109(10), 480 (7pp). | en |
dc.identifier.endpage | 7 | en |
dc.identifier.issn | 0332-3102 | |
dc.identifier.issued | 10 | en |
dc.identifier.journaltitle | Irish Medical Journal | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/5432 | |
dc.identifier.volume | 109 | en |
dc.language.iso | en | en |
dc.publisher | Irish Medical Organisation | en |
dc.relation.uri | http://imj.ie/novemberdecember-2016-vol-109-no-10/ | |
dc.rights | © 2016, Irish Medical Journal. All rights reserved. | en |
dc.subject | Anticoagulants | en |
dc.subject | Medicines | en |
dc.subject | Heart disease | en |
dc.title | A cost minimisation analysis of NOACs compared to warfarin to attain therapeutic anticoagulation amongst AF patients, pre- and post-cardioversion | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- A_Cost_Minimisation_Analysis_of_NOACs_compared_to_Warfarin_...........pdf
- Size:
- 508.31 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published Version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: